Synthesis of a series of vicinal diamines with potential biological activity

[1] L.H. DeRiemer, C.F. Meares, D.A. Goodwin and C.I. Diamanti: “Bledta-II synthesis of a new tumor-visualizing derivative of Co(III)-bleomycin”,J. Labelled Compd. Radiopharm., Vol. 18, (1981), pp. 1517–1534. http://dx.doi.org/10.1002/jlcr.258018101710.1002/jlcr.2580181017Search in Google Scholar

[2] S. Kasina, A.R. Fritzberg, D.L. Jonhson and D.J. Eshima: “Tissue distribution properties of technetium-99m-diamide-dimercaptide complexes and potential use as renal radiopharmaceuticals”,J. Med. Chem., Vol. 29, (1986), pp. 1933–1940. http://dx.doi.org/10.1021/jm00160a02310.1021/jm00160a023Search in Google Scholar

[3] J.-M. Lehn: “Cryptates: the chemistry of macropolycyclic inclusion complexes”,Acc. Chem. Res., Vol. 11, (1978), pp. 49–57. http://dx.doi.org/10.1021/ar50122a00110.1021/ar50122a001Search in Google Scholar

[4] A.E. Popter: “Pyrazines and their benzo derivatives”, In: A.R. Katritzky and C.W.C. Rees (Eds): Comprehensive Heterocyclic Chemistry, Vol. 3, Pergamon Press, Oxford, 1984, p. 179. Search in Google Scholar

[5] Review: D. Leucet, T. Legall and C. Mioskowski: “The chemistry of vicinal diamines”,Angew. Chem., Int. Ed., Vol. 37, (1998), pp. 2580–2627. http://dx.doi.org/10.1002/(SICI)1521-3773(19981016)37:19<2580::AID-ANIE2580>3.0.CO;2-L10.1002/(SICI)1521-3773(19981016)37:19<2580::AID-ANIE2580>3.0.CO;2-LSearch in Google Scholar

[6] B. Rosenberg, L. VanCamp, J.E. Trosko and V.H. Mansour: “Platinum compounds—a new class of potent antitumor agents”,Nature, Vol. 222, (1969), pp. 385–386. Search in Google Scholar

[7] H. Brunner, P. Hankofer, U. Holzinger, B. Treittinger and H. Schönenberger: “Synthesis and antitumor activity of platinum(II) complexes containing substituted ethylenediamine ligands”,Eur. J. Med. Chem., Vol. 25, (1990), pp. 35–44. http://dx.doi.org/10.1016/0223-5234(90)90162-V10.1016/0223-5234(90)90162-VSearch in Google Scholar

[8] H. Brunner, P. Hankofer, U. Holzinger and B. Treittinger: “Synthesis and antitumor-activity of Pt(II) complexes of benzyl-1,2-diaminoethane ligands”,Chem. Ber., Vol. 123, (1990), pp. 1029–1038. Search in Google Scholar

[9] R. Gust, T. Burgemeister, A. Mannschreck and H. Schönenberger: “Aqua[1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethylenediamine](sulfato)platinum(II) complexes with variable substituents in the 2-phenyl ring. 1. Synthesis and antitumor and estrogenic properties”,J. Med. Chem., Vol. 33, (1990), pp. 2535–2544. http://dx.doi.org/10.1021/jm00171a03110.1021/jm00171a031Search in Google Scholar

[10] L.R. Kelland, G. Abel, M.J. McKeage, M. Jones, P.M. Goddard, M. Valenti, B.A. Murrer and K.R. Harrap: “Preclinical antitumor evaluation of bis-acetato-amminedichloro-cyclohexylamine platinum (IV): an orally active platinum drug”,Cancer Res., Vol. 53, (1993), pp. 2581–2586. Search in Google Scholar

[11] D.-K. Kim, Y.-W. Kim, H.-T. Kim and K.H. Kim: “Synthesis andin vitro cytotoxicity ofcis-dichloro [(2S,3R,4S)-2-aminomethyl-3,4-(O-isopropylidene) dihydroxy-or-3,4-dihydroxypyrrolidine]platinum(II)”,Biiorg. Med. Chem. Lett., Vol. 6, (1996), pp. 643–646. http://dx.doi.org/10.1016/0960-894X(96)00088-110.1016/0960-894X(96)00088-1Search in Google Scholar

[12] A.R. Khokkar, S. Al-Baker, S. Shamsuddin and Z.H. Siddik: “Chemical and biological studies on a series of novel (trans-(1R,2R)-, trans-(1S,2S)-, and cis-1,2-diaminocyclohexane)platinum(IV) carboxylate complexes”,J. Med. Chem., Vol. 40, (1997), pp. 112–116. http://dx.doi.org/10.1021/jm960587l10.1021/jm960587lSearch in Google Scholar

[13] A. Pasini and F. Zunino: “New cisplatin analogs—on the way to better antitumor agents”,Angew. Chem., Int. Ed., Vol. 26, (1987), pp. 615–624. http://dx.doi.org/10.1002/anie.19870615110.1002/anie.198706151Search in Google Scholar

[14] J. Reedijk: “Improved understanding in platinium antitumour chemistry”,Chem. Commun., (1996), pp. 801–806. 10.1039/cc9960000801Search in Google Scholar

[15] S.E. Sousa, P. O'Brien and P. Poumellec: “Two expedient methods for the preparation of chiral diamines”,J. Chem. Soc., Perkin Trans. 1, (1998), pp. 1483–1492. Search in Google Scholar

[16] B.E. Rossiter, M. Eguchi, G. Miao, N.M. Swingle, A.E. Hernandez, E. Fluckiger, D. Vickers, R.G. Patterson and K.L. Reddy: “Enantioselective conjugate addition to cyclic enones with scalemic lithium organo(amido) cuprates, Part IV. Relationshipbetween ligand structure and enantioselectivity”,Tetrahedron, Vol. 49, (1993), pp. 965–986. http://dx.doi.org/10.1016/S0040-4020(01)86278-510.1016/S0040-4020(01)86278-5Search in Google Scholar

[17] R.K. Dieter, B. Lagu, J.W. Deiter, N. Deo and W.T. Pennington: „Synthesis of chiral triamine ligands from ephedrine and pseudoephedrine”,Synlett, (1990), pp. 109–110. Search in Google Scholar

[18] R.K. Dieter, N. Deo, B. Lagu and J.W. Deiter: „Stereo- and regioselective synthesis of chiral diamines and triamines from pseudoephedrine and ephedrine”,J. Org. Chem., Vol. 57, (1992), pp. 1663–1673. http://dx.doi.org/10.1021/jo00032a01310.1021/jo00032a013Search in Google Scholar

[19] P. O'Brien and T.D. Towers: “Diamine synthesis: Exploring the regioselectivity of ring opening of aziridinium ions”,J. Org. Chem., Vol. 67, (2002), pp. 304–307; and references cited therein. http://dx.doi.org/10.1021/jo010824e10.1021/jo010824eSearch in Google Scholar PubMed

[20] D. Bhuniya, A. DattaGupta and V. Singh: “Design, Synthesis, and Application of Chiral Nonracemic Lithium Amide Bases in Enantioselective Deprotonation of Epoxides”,J. Org. Chem., Vol. 61, (1996), pp. 6108–6113. http://dx.doi.org/10.1021/jo960244v10.1021/jo960244vSearch in Google Scholar PubMed